Skip to content

Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening

Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07404657
Enrollment
198
Registered
2026-02-11
Start date
2026-02-01
Completion date
2026-04-01
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy (DR)

Brief summary

This study is being done to evaluate the performance of a software that uses artificial intelligence to analyze photographs of the retina to help detect diabetic retinopathy. The study will also assess the safety of the software in combination with a fundus camera already available on the market. This software analyzes retinal photographs to detect more than mild diabetic retinopathy in adults with diabetes. The results will be compared to expert human evaluations.

Interventions

DEVICEautomatic analysis of fundus images performed by the software tool based on artificial intelligence

the duration of the intervention is the analysis performed by the software tool based on fundus images acquired

Sponsors

Centervue SpA
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 22 years old or older * diabetes or diabetic retinopathy * understand the study information and able to sign a consent form

Exclusion criteria

* cannot tolerate eye imaging tests * laser treatment or injections * eye surgery, except for simple cataract surgery * currently involved in another study * pregnant * cannot or do not want to have your eyes dilated * photodynamic therapy within the last 90 days

Design outcomes

Primary

MeasureTime frame
Number of subjects whose results provided by the automatic AI-based tool match the reading center grading for the identification of referable diabetic eye disease (more than mild DR).1-day visit

Secondary

MeasureTime frame
percentage of eyes for which the AI-based automatic tool produced a result1-day visit

Contacts

CONTACTRui
chiara.rui@icare-world.com00393357442593
CONTACTRumiato
ra.imaging@icare-world.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026